Table 1 Data summary and comparison between progression and non-progression groups
Non-progression (N = 22) | Progression (N = 12) | P value | |
|---|---|---|---|
Demographics | |||
Age | 49.5 ± 16.1 | 47.9 ± 16.6 | 0.788 |
Follow-up (months) | 30.8 ± 42.3 | 50.2 ± 38.4 | 0.106 |
Sex | 0.097 | ||
Female | 10 (45.5%) | 9 (75.0%) | |
Male | 12 (54.5%) | 3 (25.0%) | |
BMI (kg/m2) | 23.6 ± 4.2 | 25.8 ± 5.7 | 0.268 |
Bilateral lesions | 0.687 | ||
Present | 5 (22.7%) | 4 (33.3%) | |
Etiology | |||
Alcoholics | 3 (13.6%) | 1 (8.3%) | 1.000 |
Steroid Use | 4 (18.2%) | 4 (33.3%) | 0.410 |
Post-traumatic | 6 (27.3%) | 4 (33.3%) | 0.714 |
Recurrent sprain | 5 (22.7%) | 1 (8.3%) | 0.389 |
SLE | 2 (9.1%) | 4 (33.3%) | 0.154 |
AVN characteristics | |||
Location | 0.066 | ||
Non-shoulder lesion | 12 (54.5%) | 2 (16.7%) | |
Shoulder lesion | 10 (45.5%) | 10 (83.3%) | |
Involvement of other joints | 1.000 | ||
Present | 5 (22.7%) | 3 (25.0%) |